Literature DB >> 33591949

Down-regulation of estrogen-related receptor alpha (ERRα) inhibits gastric cancer cell migration and invasion in vitro and in vivo.

Yuejiao Zhong1, Kang He1, Lin Shi1,2, Lingxiang Chen1, Bin Zhou3, Rong Ma4, Hui Yu5, Jia Zhang6, You Shuai1, Yan Fei1, Jianwei Lu1,2.   

Abstract

OBJECTIVE: To investigate the correlation between estrogen-related receptor a (ERRα) expression level and gastric cancer (GC).
METHODS: We collected GC and adjacent normal tissues from 50 patients. The parameters of the patients were summarized, and correlation with the expression level of ERRα was calculated. Downregulated ERRα using lentivirus was designed and transfected to SGC-7901 and MGC-803 cells. Cell migration, invasion and wound assays were conducted to determine the correlation between ERRα and capacity for cell migration and invasion. The expression level of the genes involved in epithelial-mesenchymal transition, including E-cadherin, γ-catenin, N-cadherin and vimentin, was determined via real-time or quantitative polymerase chain reaction(qPCR) and Western blot analysis.
RESULTS: The expression of ERRα tends to be higher in GC tissues than in adjacent normal tissues. Analyses ofthe expression level of ERRα and patient parameters show that the ERRα level is significantly correlated with TNM staging and patient survival (P<0.05). The downregulation of ERRα can inhibit cell invasion and migration, which was proven by Transwell and cell wound assays. The levels of E-cadherin and γ-catenin increased by conducting qPCR and Western blot analysis. Meanwhile, the levels of N-cadherin and vimentin decreased when ERRα expression was reduced.
CONCLUSION: ERRα is highly expressed in GC tissues and can promote the migration and invasion of cancer cells. It can be a potential marker for GC diagnosis.

Entities:  

Keywords:  epithelial–mesenchymal transition; estrogen-related receptor alpha; gastric cancer

Mesh:

Substances:

Year:  2021        PMID: 33591949      PMCID: PMC7950300          DOI: 10.18632/aging.202508

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  29 in total

1.  The metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer.

Authors:  Ching-yi Chang; Dmitri Kazmin; Jeff S Jasper; Rebecca Kunder; William J Zuercher; Donald P McDonnell
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

Review 2.  Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?

Authors:  Erik W Thompson; Donald F Newgreen; David Tarin
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

Review 3.  Complex networks orchestrate epithelial-mesenchymal transitions.

Authors:  Jean Paul Thiery; Jonathan P Sleeman
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  Increased expression of estrogen-related receptor alpha (ERRalpha) is a negative prognostic predictor in human prostate cancer.

Authors:  Tetsuya Fujimura; Satoru Takahashi; Tomohiko Urano; Jinpei Kumagai; Tetsuo Ogushi; Kuniko Horie-Inoue; Yasuyoshi Ouchi; Tadaichi Kitamura; Masami Muramatsu; Satoshi Inoue
Journal:  Int J Cancer       Date:  2007-06-01       Impact factor: 7.396

6.  Estrogen-related receptor-alpha antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts.

Authors:  Michael J Chisamore; Hilary A Wilkinson; Osvaldo Flores; J Don Chen
Journal:  Mol Cancer Ther       Date:  2009-03-10       Impact factor: 6.261

7.  Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.

Authors:  Takashi Suzuki; Yasuhiro Miki; Takuya Moriya; Norihiro Shimada; Takanori Ishida; Hisashi Hirakawa; Noriaki Ohuchi; Hironobu Sasano
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

Review 8.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

9.  Clinical implication of estrogen-related receptor (ERR) expression in uterine endometrial cancers.

Authors:  Jiro Fujimoto; Eriko Sato
Journal:  J Steroid Biochem Mol Biol       Date:  2009-05-03       Impact factor: 4.292

10.  Genomic amplification upregulates estrogen-related receptor alpha and its depletion inhibits oral squamous cell carcinoma tumors in vivo.

Authors:  Ankana Tiwari; Shivananda Swamy; Kodaganur S Gopinath; Arun Kumar
Journal:  Sci Rep       Date:  2015-12-07       Impact factor: 4.379

View more
  2 in total

1.  Estrogen Related Receptor Alpha (ERRα) a Bridge between Metabolism and Adrenocortical Cancer Progression.

Authors:  Paola Avena; Arianna De Luca; Adele Chimento; Marta Claudia Nocito; Sara Sculco; Davide La Padula; Lucia Zavaglia; Matteo Giulietti; Constanze Hantel; Rosa Sirianni; Ivan Casaburi; Vincenzo Pezzi
Journal:  Cancers (Basel)       Date:  2022-08-11       Impact factor: 6.575

2.  Achaete-scute complex-like 2 regulated inflammatory mechanism through Toll-like receptor 4 activating in stomach adenocarcinoma.

Authors:  Enqi Zheng; Zhun Cai; Wangyong Li; Chuandou Ni; Qian Fang
Journal:  World J Surg Oncol       Date:  2022-08-25       Impact factor: 3.253

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.